Timothy J. Maziasz

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life

Jane L. Wang, David C. Limburg, Matthew J. Graneto et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 335 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Pharmacokinetics of Celecoxib after Oral Administration in Dogs and Humans: Effect of Food and Site of Absorption

Susan K. Paulson, Margaret B. Vaughn, Susan M. Jessen et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 286 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Interspecies Differences in Renal Localization of Cyclooxygenase Isoforms: Implications in Nonsteroidal Antiinflammatory Drug-Related Nephrotoxicity

Kanwar Nasir M. Khan, Catherine M. Venturini, Roderick T. Bunch et al. · Toxicologic Pathology · 1998 · 203 citations

Medicine, Nephrology, Pharmacology +17

Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats

Susan K. Paulson, Ji Y. Zhang, Alan P. Breau et al. · Drug Metabolism and Disposition · 2000 · 131 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib

Susan K. Paulson, Leslie Engel, Suzanne Bolten et al. · Drug Metabolism and Disposition · 1999 · 117 citations

Medicine, Pharmacokinetics, Pharmacology +17